Navigation Links
Reportlinker Adds Global Analgesics Industry
Date:11/16/2010

Extends Licensing Agreement with Ortho-McNeil 42

China Aoxing Pockets LRT 42

Anesiva Inks Joint Venture Agreement Wanbang 42

Beijing Med-Pharm Inks Agreement with Lotus Healthcare 42

LAB International Inks Licensing Agreement with Janssen

Pharmaceutica 43

Three Sixty Pockets Rockford-Montgomery Labs 43

Antares Enters into License and Development Agreement for

Opioid Analgesic 43

Abraxis BioScience Acquires AstraZeneca's Analgesic Brand

Portfolio 43

IntelliPharmaCeutics Inks Agreement with Larasan 43

Ranbaxy and Ethypharm Ink In-licensing Agreement 44

Elite Collaborates with TPN to Co-develop Analgesic Drug 44

Novartis Acquires Hexal Company and Major Stake in Eon Labs . 44

NovaDel Pharma Receives Patent for Buccal Sprays Technology 44

Auxilium Pharmaceuticals Enters into a Licensing Agreement

with PharmaForm 44

EC Sanctions Sale of Elan's Prialt 45

EpiCept Corp. Merges with Maxim Pharmaceuticals, Inc 45

Reckitt Benckiser plc Acquires Boots Healthcare International 45

11. FOCUS ON SELECT KEY PLAYERS 46

Bayer Consumer Care (US) 46

Johnson & Johnson (US) 46

McNeil Consumer Healthcare (Canada) 46

Novartis International AG (Switzerland) 46

Pfizer Inc. (US) 47

Reckitt Benckiser Group Plc (UK) 47

Sanofi Aventis S.A. (France) 47

12. GLOBAL MARKET PERSPECTIVE 48

Table 2: World Recent Past, Current & Future Analysis for

Analgesics by Geographic Region/Country - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years2007 through 2015 (includes

corresponding Graph/Chart) 48

Table 3: World Historic Review for Analgesics by Geographic

Region/Country - US, Canada, Japan, Europe, Asia-Pacific

(excl
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Reportlinker Adds Top Ten Worlds Leading Pharmaceutical Companies
2. Reportlinker Adds Top Ten Worlds Leading Life Science Intermediates Companies
3. Reportlinker Adds Global Blood Glucose Meters and Strips Industry
4. Reportlinker Adds Global Ambulatory & Bathroom Aids Industry
5. Reportlinker Adds Global Insulin Pumps (External) Industry
6. Reportlinker Adds Global Antibiotics Industry
7. Reportlinker Adds Global Medical Specialty Bags Industry
8. Reportlinker Adds Global Ophthalmic Instrumentation Industry
9. Reportlinker Adds Global Nuclear Medicine Industry
10. Reportlinker Adds U.S. Inflammatory Diseases Drug Delivery: Physician Perspective
11. Reportlinker Adds Proteomics - Technologies, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: ... Phase I trial of Lixte,s lead compound, LB‑100, is being ... John S. Kovach , M.D., the founder and ... to be completed at a single site. Accrual of patients, ...
(Date:1/23/2015)... , Jan. 23, 2015 Gem Pharmaceuticals announced ... have been enrolled into the Company,s Phase 2 clinical ... safety of Gem,s lead compound, GPX-150 (an investigational medication), ... or metastatic disease. Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/22/2015)... UPI ), a medical device company that develops, manufactures ... today reported financial results for the fiscal 2015 third ... the Company,s Urgent ®  PC Neuromodulation System grew 14.5% ... compared to $3.9 million in the third quarter of ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18
... Inc. (Nasdaq: QCOR ) has completed a ... as its independent, registered public accounting firm for the ... BDO to replace Odenberg Ullakko Muranishi & Co. LLP ... "As we continue our strategy to grow through ...
... 4, 2011 Doctors at Beaumont Hospital, Troy ... to correct atrial fibrillation, a prevalent and growing ... is an alternative to open-heart surgery. It,s performed ... a shorter hospital stay. Phillip Robinson, ...
Cached Medicine Technology:Questcor Pharmaceuticals Selects BDO USA as its Auditor 2Beaumont First in State to Perform Robotic Heart Procedure for Atrial Fibrillation 2Beaumont First in State to Perform Robotic Heart Procedure for Atrial Fibrillation 3
(Date:1/22/2015)... January 22, 2015 Autocarinsurancebest.com has released a ... a commercial auto insurance policy . , Auto insurance ... vehicles. It is no longer necessary to call an agent ... now available online on a single website: http://autocarinsurancebest.com/ . ...
(Date:1/22/2015)... Joan Lunden, award-winning American journalist, beloved television host, ... 32nd Annual Miami Breast Cancer Conference planned and ... , shares that “a fast-growing, virulent” cancer in her ... not followed up her clean mammogram with an ultrasound. ...
(Date:1/22/2015)... 2015 Recently, Weddingshe.com has added many trendy ... announced its highest annual revenues in the past three years. ... glamorous wedding dresses. , According to the sales manager of ... promotions for them in 2015. This point can be reflected ...
(Date:1/22/2015)... DC (PRWEB) January 22, 2015 Payday ... in vulnerable communities and cause financial distress to the ... by analysts at Howard University’s Center on Race and ... dollars in economic activity, payday loans at the same ...
(Date:1/22/2015)... 22, 2015 JJsHouse.com is a famous dress ... the business announces its latest collection of wedding dresses ... most important issue is the wedding dress on your big ... a woman’s life. Every bride wants to find the most ...
Breaking Medicine News(10 mins):Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... Study,s conclusion of no causal link disputes its own ... conflicts of interest, NIXA, Mo., Sept. 26 ... of only 1047 participants, low,compliance rate, and very little ... any reputable journal -- appears to misinform,the public. They ...
... when LDL levels were low, study finds , , WEDNESDAY, ... HDL cholesterol protect against heart disease and stroke no ... are, a new study shows. , The incidence of ... percent lower in the one-fifth of participants in a ...
... (Nasdaq: AMCS ),a leader in radiology and medical image and ... investors at the William Blair & Company Small Cap Growth Stock,Conference ... ), WHEN: ... -- Presentation begins promptly at 11:20 a.m. (Eastern Time), ...
... Ramps ... Million, CHICAGO, Sept. 26 Since its launch in April, more ... and have lost more than three-quarters of a million pounds.,Challenge founder Dr. ... will lead the way to a million pounds lost by the,final stop ...
... Improvement Organization is part of national effort to ... improve health of Medicare ... (QIOs) across the country are working in partnership with,Medicare ... plans,(MA-PDs) to improve the quality of prescription drug therapy ...
... Cancer Awareness in New Hampshire and Seek ... MANCHESTER, N.H., Sept. 26 Susan G. Komen,for ... public policy campaign aimed at,educating and mobilizing New ... make breast cancer a priority -- in their,platforms, ...
Cached Medicine News:Health News:CDC Study Links Thimerosal in Vaccines to Motor/Phonic Tics and Deficits in Attention, Behavior Control, Verbal IQ 2Health News:High HDL Levels Protect Heart Health 2Health News:AMICAS to Present at William Blair & Company Small Cap Growth Stock Conference 2Health News:The Challenge: Make It A Million (Pounds Lost That Is) 2Health News:The Challenge: Make It A Million (Pounds Lost That Is) 3Health News:Delmarva Foundation Implements Medication Therapy Management Program in Maryland and DC 2Health News:Komen for the Cure Launches 'Presidential' Campaign 2
... temperature set by means of a ... button. A green LED indicates the ... amber LED indicates the unit has ... LED and an audible alarm indicates ...
Provides outstanding patient warming and safety throughout the hospital and is nearly half the size and one-third the weight of earlier units....
The QuickVue Advance® G. vaginalis test is an enzyme activity test for use in the detection of Gardnerella vaginalis Proline IminoPeptidase(PIP) activity in vaginal fluid specimens from women su...
The Affirm™ VPIII tests RNA probe technology offers a dependable, rapid means toward early identification and treatment of patients suffering from these pathogens....
Medicine Products: